Evolution and safety of day-case major ear surgery.


Journal

European annals of otorhinolaryngology, head and neck diseases
ISSN: 1879-730X
Titre abrégé: Eur Ann Otorhinolaryngol Head Neck Dis
Pays: France
ID NLM: 101531465

Informations de publication

Date de publication:
May 2021
Historique:
pubmed: 14 10 2020
medline: 26 10 2021
entrez: 13 10 2020
Statut: ppublish

Résumé

To study the evolution of middle-ear surgery in 2019 in relation to the French Health Authority target of 66% day-surgery by 2020. A single-center retrospective observational study included all patients undergoing otologic surgery between January 2014 and December 2018 in a university hospital center. 1064 of the 1368 patients were scheduled for outpatient surgery: 309 for otosclerosis, 355 for tympanoplasty with or without ossiculoplasty, 376 for cholesteatoma and 24 for other procedures. Two groups were constituted: day-surgery and conventional, according to hospital stay. Surgery time, follow-up duration, number of crossovers to conventional admission, number of emergency postoperative consultations, number of readmissions and data from the phone-call systematically made the day after surgery were analyzed. The main objective was to evaluate the safety of outpatient surgery for major middle-ear interventions compared to a control group managed under conventional admission during the same period. 27 patients (2.5%) required crossover, mainly due to disabling vertigo (57.7%). 53 patients (4.9%) consulted before the scheduled 8th day consultation, because of severe pain (23.5%) or dizziness (34.0%). Only 10 patients required emergency readmission. Provided that the inclusion criteria are met, all major middle-ear surgery procedures can be performed as day-surgery under satisfactory safety conditions.

Identifiants

pubmed: 33046425
pii: S1879-7296(20)30215-5
doi: 10.1016/j.anorl.2020.09.006
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

141-145

Informations de copyright

Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Auteurs

S Bonnafous (S)

Service d'otologie et d'otoneurologie, hospices civils de Lyon, centre hospitalier Lyon Sud, université de Lyon, université Claude-Bernard Lyon 1, 69495 Pierre-Bénite, France.

R Hermann (R)

Service d'otologie et chirurgie plastique de la face, hospices civils de Lyon, hôpital Edouard-Herriot, université de Lyon, université Claude-Bernard Lyon 1, 69003 Lyon, France.

S Zaouche (S)

Service d'otologie et d'otoneurologie, hospices civils de Lyon, centre hospitalier Lyon Sud, université de Lyon, université Claude-Bernard Lyon 1, 69495 Pierre-Bénite, France.

S Tringali (S)

Service d'otologie et d'otoneurologie, hospices civils de Lyon, centre hospitalier Lyon Sud, université de Lyon, université Claude-Bernard Lyon 1, 69495 Pierre-Bénite, France.

M Fieux (M)

Service d'otologie et d'otoneurologie, hospices civils de Lyon, centre hospitalier Lyon Sud, université de Lyon, université Claude-Bernard Lyon 1, 69495 Pierre-Bénite, France. Electronic address: maxime.fieux@chu-lyon.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH